share_log

6 Analysts Assess Amylyx Pharma: What You Need To Know

6 Analysts Assess Amylyx Pharma: What You Need To Know

6位分析师评估Amylyx Pharma:你需要知道的
Benzinga ·  06/24 08:00
Across the recent three months, 6 analysts have shared their insights on Amylyx Pharma (NASDAQ:AMLX), expressing a variety of opinions spanning from bullish to bearish.
在过去的三个月中,6位分析师将他们对Amylyx Pharma(纳斯达克:AMLX)的见解分享出来,表达了从看好到看淡的各种观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照,展示了情绪在过去30天中的演变情况,并将其与之前的月份进行比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $6.33, a high estimate of $8.00, and a low estimate of $3.00. A decline of 1.09% from the prior average price target is evident in the current average.
分析师评估的12个月价格目标揭示了更多的信息,其中包括平均目标价为6.33美元,最高预估价为8美元,最低预估价为3美元。当前的平均价格目标较前一个平均价格目标下降了1.09%。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级:更深入的了解
The standing of Amylyx...
通过对最...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发